Matthew Warr

Affiliations: 
2013 University of California, San Francisco, San Francisco, CA 
Google:
"Matthew Warr"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kang YA, Paik H, Zhang SY, et al. (2023) Secretory MPP3 reinforce myeloid differentiation trajectory and amplify myeloid cell production. The Journal of Experimental Medicine. 220
Gaillard C, Surianarayanan S, Bentley T, et al. (2018) Identification of IRF8 as a potent tumor suppressor in murine acute promyelocytic leukemia. Blood Advances. 2: 2462-2466
Ho TT, Warr MR, Adelman ER, et al. (2017) Autophagy maintains the metabolism and function of young and old stem cells. Nature
Ugarte F, Sousae R, Cinquin B, et al. (2015) Progressive Chromatin Condensation and H3K9 Methylation Regulate the Differentiation of Embryonic and Hematopoietic Stem Cells. Stem Cell Reports. 5: 728-740
Asshoff M, Warr M, Haschka D, et al. (2015) The Jak1/Jak2 Inhibitor Momelotinib Inhibits Alk2, Decreases Hepcidin Production and Ameliorates Anemia of Chronic Disease (ACD) in Rodents Blood. 126: 538-538
Warr MR, Kohli L, Passegué E. (2013) Born to survive: autophagy in hematopoietic stem cell maintenance. Cell Cycle (Georgetown, Tex.). 12: 1979-80
Warr MR, Binnewies M, Flach J, et al. (2013) FOXO3A directs a protective autophagy program in haematopoietic stem cells. Nature. 494: 323-7
Warr MR, Passegué E. (2013) Metabolic makeover for HSCs. Cell Stem Cell. 12: 1-3
Pietras EM, Warr MR, Passegué E. (2011) Cell cycle regulation in hematopoietic stem cells. The Journal of Cell Biology. 195: 709-20
Garcia D, Warr MR, Martins CP, et al. (2011) Validation of MdmX as a therapeutic target for reactivating p53 in tumors. Genes & Development. 25: 1746-57
See more...